SCHEMBL762127

SCHEMBL762127

C[Si](C)(C)c1ccc(N(c2ccccc2)c2ccc3c(-c4ccc(-c5ccccc5-c5ccccc5)cc4)c4cc(N(c5ccccc5)c5ccc([Si](C)(C)C)cc5)ccc4c(-c4ccc(-c5ccccc5-c5ccccc5)cc4)c3c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 1/20 0.33
TDP1 Q9NUW8 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
MAPT P10636 3/20 0.31
GPR84 Q9NQS5 1/20 0.30
ACHE P22303 2/20 0.30
ALDH1A1 P00352 2/20 0.30
L3MBTL1 Q9Y468 2/20 0.30
KDM4E B2RXH2 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
USP2 O75604 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761402 0.93 PTAFR (0.32) PTAFRTDP1MEN1KMT2ATHRB
SCHEMBL760840 0.93 TDP1 (0.33) PTAFRTDP1MEN1KMT2ATHRB
SCHEMBL761434 0.92 PTAFR (0.33) PTAFRTDP1MEN1KMT2AMAPT
SCHEMBL14516043 0.92 ACHE (0.33) PTAFRTDP1MEN1KMT2ATHRB
SCHEMBL14516040 0.92 ACHE (0.33) PTAFRTDP1MEN1KMT2ATHRB
SCHEMBL760861 0.92 ACHE (0.33) PTAFRTDP1MEN1KMT2ATHRB
SCHEMBL14515982 0.92 TDP1 (0.33) TDP1MEN1KMT2ATHRBRECQL
SCHEMBL760843 0.89 ENPP1 (0.39) TDP1MAPTGPR84ALDH1A1L3MBTL1
SCHEMBL761302 0.88 ENPP1 (0.38) TDP1MAPTGPR84ALDH1A1L3MBTL1
SCHEMBL760842 0.86 APP (0.43) MAPTALDH1A1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8137823-B2 Anthracene derivatives, process for preparation thereof, and organic electronic light emitting device using the same LG CHEM, LTD. (KR) 2012-03-20 US disclosed
US-20090079334-A1 Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same LG CHEM, LTD. (KR) 2009-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090079334-A1 Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same XPOT, ALAD, APRT PTAFR 4759/4885TDP1 2558/4885MEN1 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.